Published: February 25, 2025
Pediatric oncology’s remarkable strides improving survival for children with cancer also has brought a new set of long-term health implications.
Recognizing these survivors’ unique needs and implementing a collaborative approach to care, as well as continued research and education, can improve quality of life and long-term health outcomes, according to Kerry K. McGowan, M.D., pediatric oncologist with Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine.
The five-year survival rate for childhood cancers now exceeds 85%, and more than 500,000 individuals are navigating the long-term consequences of their treatment. Most of these survivors are between 20 and 40 years old, a critical period for life transitions such as education, career development and family formation.
Childhood cancer survivors average 17 chronic medical conditions by the time they reach their 50s, according to Dr. McGowan. These late effects encompass a wide range of physical and psychosocial challenges.
Cardiomyopathy and heart failure are a few of the significant risks of certain cancer treatment protocols that include anthracycline chemotherapy and chest radiation that can be so effective in curing certain cancers.
“We are aware that the anthracycline chemotherapy and radiotherapy have dose-related heart toxicities, and the current treatment protocols try to limit the exposure to these therapies where possible, but it is sometimes unavoidable,” Dr McGowan said.
Fibrosis, or stiffness of the lungs, and pneumonitis can be additional late effects, particularly due to radiation therapy.
The Childhood Cancer Survivorship Study (CCSS), a landmark cohort study, has been instrumental in elucidating the long-term health outcomes of survivors treated between the 1970s and 1990s. CCSS data has highlighted the prevalence and severity of late effects, emphasizing the need for ongoing surveillance and management.
To refer a patient to Norton Children’s Cancer Institute, visit NortonEpicCareLink.com and open an order for Pediatric Oncology.
Refer online
Call (502) 599-PEDS (7337)
Addressing the complex needs of childhood cancer survivors requires a multidisciplinary approach. This team should include: